These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 1948918)

  • 1. [Hypertension as a part of metabolic cardiovascular syndrome].
    Os I; Hjermann I; Nordby G
    Tidsskr Nor Laegeforen; 1991 Oct; 111(25):3062-4. PubMed ID: 1948918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
    Kjeldsen SE; Rostrup M; Moan A; Mundal HH; Gjesdal K; Eide IK
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S32-9. PubMed ID: 1283768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and hypertension: a review.
    Sowers JR; Khoury S
    Prim Care; 1991 Sep; 18(3):509-24. PubMed ID: 1658839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors.
    Hernández-Mijares A; Jarabo-Bueno MM; López-Ruiz A; Solá-Izquierdo E; Morillas-Ariño C; Martínez-Triguero ML
    Int J Obes (Lond); 2007 Jun; 31(6):927-32. PubMed ID: 17264851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin resistance and arterial hypertension].
    Weidmann P; Müller-Wieland D; de Courten M; Krone W
    Herz; 1995 Feb; 20(1):16-32. PubMed ID: 7713473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reduced glucose tolerance as a risk factor of cardiovascular diseases].
    Holmen J
    Tidsskr Nor Laegeforen; 1994 Jun; 114(15):1700-3. PubMed ID: 8079281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus.
    Hodge AM; Dowse GK; Zimmet PZ
    Diabet Med; 1996 May; 13(5):441-9. PubMed ID: 8737026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and hypertension. Patients in double jeopardy for cardiovascular disease.
    McLaughlin T; Reaven G
    Geriatrics; 2000 Jun; 55(6):28-32, 35. PubMed ID: 10872343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of vascular disease in hypertension with special reference to diabetes.
    Yudkin JS
    Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin receptor blockers: Cardiovascular protection in the metabolic syndrome.
    Deedwania PC; Schmieder R
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7 Suppl 1():S12-8. PubMed ID: 16986230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The metabolic syndrome: common etiology for distinct cardiovascular risk factors?].
    Weisser B; Locher R; Vetter W
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1339-43. PubMed ID: 8272698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The metabolic syndrome. Pathophysiologic causes, diagnosis, therapy].
    Rett K; Wicklmayr M; Standl E
    Wien Klin Wochenschr; 1994; 106(24):750-7. PubMed ID: 7846893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it hyperinsulinemia or insulin resistance that is related to hypertension and other metabolic cardiovascular risk factors?
    Lind L; Lithell H; Pollare T
    J Hypertens Suppl; 1993 Jun; 11(4):S11-6. PubMed ID: 8377030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypertension and other cardiovascular risk factors in patients with metabolic syndrome.
    Suzuki T; Homma S
    Med Clin North Am; 2007 Nov; 91(6):1211-23, x. PubMed ID: 17964917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A central role of eNOS in the protective effect of wine against metabolic syndrome.
    Leighton F; Miranda-Rottmann S; Urquiaga I
    Cell Biochem Funct; 2006; 24(4):291-8. PubMed ID: 16170835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.